What\u2019s next?<\/p>\n
The team now plans to shift from an ex vivo research system to a practical intraoperative tool.<\/p>\n
\u201cIt means making the system faster, easier to use, and fully compatible with the operating room,\u201d Gruev says.<\/p>\n
They will also need to conduct larger clinical studies to test the approach across more patients and more clinical settings. Another important step will be to improve the UV sensitivity to produce stronger signals with shorter exposure times and lower light levels. Any clinical instrument using UV light will need careful dose control, as well, and built-in safety monitoring.<\/p>\n
\u201cOur ultimate goal is to give surgeons useful optical information in real time, without disrupting the normal surgical workflow,\u201d Gruev says.<\/p>\n
Broader goals<\/p>\n
True positive outcomes in cancer treatment will require more precise surgery.<\/p>\n
\u201cCancer surgeons are always balancing two priorities: Removing enough tissue to treat the disease, while preserving as much healthy tissue as possible,\u201d Gruev says. \u201cFor lymph node surgery, that balance is especially important.\u201d<\/p>\n
Removing too many lymph nodes can increase complications such as lymphedema, the swelling of tissue caused by an accumulation of protein-rich fluid. This fluid is usually drained through a healthy lymphatic system.<\/p>\n
Missing the lymph nodes involved can affect staging and treatment. \u201cA tool like this could help surgeons make more informed decisions during the operation,\u201d Gruev says.<\/p>\n
Beyond this, surgical cameras could potentially do more than just show anatomy. They may also provide real-time optical information about tissue biology, which could ultimately help move cancer surgery toward more selective, personalized, and confident decision-making.<\/p>\n
FURTHER READING<\/p>\n